Follow the Money: Where Venture Dollars Are Flowing in 2026

Venture capital in 2026 is not a rising tide lifting all boats. It is a firehose aimed at a short list of targets. Global startups raised $679 billion in the first three quarters of the year, the most ever for that stretch, according to Crunchbase. Yet roughly two of every three dollars went to AI, and about a third of Q3's money landed in just 27 companies.

That split defines the market right now. Headline totals look like 2021. Underneath, capital is concentrating by sector, by stage, by geography and even by founding year: half of Q3 dollars went to companies founded since 2022. This post breaks down where the money is going, using the latest quarterly data, and what it means for founders and investors heading into 2027.

In Partnership with Get Access

Every deal, same economics. Founding Membership included. 

Get Access members see one vetted deals a week: growth-stage primary rounds, company approved, direct on cap table, and ordinarily sourced by 100+ Access Investors who invest in every company they bring. Every deal - clean economics, clear fees, and aligned incentives. 

• 0% management fees

• $0 setup and deal fees

• $2.5k minimum per deal

• 10% discounted carry for Founding Members

Last Money In readers skip the waitlist

The big picture: record dollars, cooling quarter by quarter

2026 is already the biggest year in venture history, and it isn't close. Crunchbase counted roughly $300 billion in Q1, $212 billion in Q2 and $159 billion in Q3. For context, the entire 2025 total was $425 billion, and that was the third-best year on record (Crunchbase, 2025 recap).

The quarterly trend is down, but from an absurd peak. Q1 was inflated by four rounds alone: OpenAI ($122 billion), Anthropic ($30 billion), xAI ($20 billion) and Waymo ($16 billion), together 65% of the quarter (Crunchbase, Q1). Q3's $159 billion was the year's lowest quarter, yet still up 53% from Q3 2025 and higher than any quarter between mid-2022 and 2025. October kept the pace, with $59 billion invested, up 45% year over year, lifted by DeepSeek's $15.9 billion round (Crunchbase, October).

The mega-round is the market. What changed in Q3 is breadth at the very top. A record 27 companies raised $1 billion-plus rounds, up from 16 in Q2 and 14 in Q1. No single round hit $10 billion; instead eight companies raised $3 billion or more, led by Databricks and Safe Superintelligence at $5 billion each, followed by Crusoe, Moonshot AI, Mistral AI, Nscale, The Boring Co. and Kling AI.

Geography is concentrated too. U.S. companies took $91 billion, or 57% of Q3's global total, and the San Francisco Bay Area alone took 24%. That U.S. share is down from 83% in Q1, as Europe posted its best quarter in four years and Asia neared a record.

By category: AI first, then everything that powers AI

AI is “the market”. AI-driven startups raised $102 billion in Q3, 64% of all venture dollars, per Crunchbase. That share actually fell from 80% in Q1 and more than 70% in Q2, then ticked back to 66% in October. For comparison, AI took about 50% of venture dollars in all of 2025.

The more interesting story is where the non-lab money goes. The 2026 wave has moved from software into atoms. In Q3, aerospace, robotics, data centers, semiconductors and energy each pulled in $10 billion or more. Crusoe, Nscale and Axiom (a $2 billion October raise for data-center power) are as much energy and real-estate plays as AI plays. Even the Series B leaderboard is physical: Jeff Bezos' Prometheus took a reported $12 billion, and nuclear startup Valar Atomics raised $1 billion (Crunchbase, Series B).

Here is how the major categories stack up right now. Note that each tracker defines sectors differently, so the figures come from different sources and shouldn't be summed.

Sources: Crunchbase Q3, Crunchbase October, PitchBook, KPMG Venture Pulse, J.P. Morgan, Dealroom, BioSpace, Crunchbase 2025 recap.

The takeaway: outside AI and the hardware stack beneath it, categories like health, fintech and enterprise software are still funded, but they are fighting for a much smaller slice. A startup that can tell an AI-infrastructure or physical-AI story has a very different fundraising market than one that can't.

By stage: growth money boomed, early money got pickier

The stage split is where 2026 gets lopsided. Late-stage rounds absorbed the swing in total funding, while seed and early-stage dollars stayed in a tight band all year.

Source: Crunchbase quarterly reports, figures as first published. Later revisions raised Q1 to about $308B and Q2 to $212B in total.

One caveat before the numbers: trackers slice stages differently. Crunchbase, used in the chart, counts Series A and B as "early" and Series C onward as "late." To match the split many founders use, pre-seed through Series A as early and Series B through pre-IPO as growth, the cleanest series-level data comes from Carta's cap-table platform (mostly U.S. startups). Its latest full report covers Q1 2026.

Source: Carta, State of Private Markets Q1 2026. Shares are of Carta's $30.4B Q1 total.

Early stage (pre-seed through Series A): more money, fewer checks. Capital is up but deal counts are falling at every early rung. Globally, Crunchbase counted $13 billion of seed funding in Q3, and $2.6 billion of that went to seed rounds of $100 million or more. Early-stage funding hit $40.6 billion, up 25% year over year, with jumbo $100 million-plus rounds making up half of early-stage financing. In Q1, seed deal counts fell 30% year over year to about 3,800 even as dollars rose 31%. In North America, Q3 deal counts dropped 16% year over year to the lowest level since 2023, and the decline was concentrated in seed and early stage (Crunchbase).

Growth stage (Series B through pre-IPO): where the dollars actually are. Late-stage funding was $105 billion in Q3, up 73% year over year, and rounds of $100 million or more made up close to 90% of it. The middle of the curve is thinning out. U.S. Series B funding reached about $48 billion so far this year, the most in years, yet round counts are on track for a multiyear low. Fewer than a third of Series B deals were under $30 million, versus about half from 2021 to 2025, and roughly two-thirds of Series B dollars went to AI companies (Crunchbase, Series B). At the top end, Carta shows Series E+ capital nearly doubling year over year, the clearest sign that pre-IPO companies are raising big ahead of listings.

The pattern is consistent across sources: the median startup is not seeing a boom. Investors are concentrating on companies with early traction and writing larger checks to them, at every stage.

What it means: liquidity is back, and the next test is public markets

The reason growth investors keep writing giant checks is that exits finally reopened. Q2 2026 set records for venture-backed IPO and M&A value, headlined by SpaceX's IPO at a $1.77 trillion value and its $60 billion deal for Anysphere, maker of Cursor (Crunchbase, H1). Q3 kept going. China's ChangXin Memory raised $8.6 billion in the quarter's largest IPO, and U.S. strategics led M&A: Nvidia bid $12.9 billion for Hugging Face, AMD agreed to buy World Labs for $8.2 billion, and Stripe bought OpenRouter for $7.5 billion.

The next big signal arrives this month. Crunchbase reports that Anthropic, the most valuable venture-backed private company, is slated to go public in November in a potential $2 trillion listing. How public investors receive it will shape whether late-stage AI valuations hold into 2027.

The bottom line: venture is having a record year, but it is a narrow one. Follow the money and it leads to AI, to the hardware that runs it, and to later-stage companies close to an exit. Whether it spreads wider depends on what happens when the biggest of those companies meet public markets.

Sources

• Crunchbase: Q3 2026 global funding

• Crunchbase: H1 2026 global funding and exits

• Crunchbase: Q1 2026 global funding

• Crunchbase: 2025 global funding recap

• Crunchbase: October 2026 global funding

• Crunchbase: More money, fewer checks

• Crunchbase: Series B funding is up, deals are down

• Carta: State of Private Markets Q1 2026

• PitchBook: Q3 2026 Defense Tech VC First Look

• KPMG: Venture Pulse Q3 2026

• J.P. Morgan: Biopharma and medtech deal reports

• Dealroom: Healthtech

✍️ Written by Zachary and Alex